Veritas Genetics which tried to make a business offering inexpensive whole genome sequencing to consumers, is going out of business in the U.S., looks like.
Had problems including a data breach and just a lack of demand from people to know their genes.
Had problems including a data breach and just a lack of demand from people to know their genes.
"Veritas in July said that it had sequenced 5,000 genomes, with a goal of sequencing more than 150,000 in 2021. The company has raised more than $50 million in venture funding, according to Crunchbase."
From story last month reporting the databreach. bloomberg.com/news/articles/…
From story last month reporting the databreach. bloomberg.com/news/articles/…
In 2017 we reported Veritas going to offer whole genome sequencing for Chinese kids, but planned offerings to that market -- predictions about baldness, musical talent -- were condemned by expert opinion here.
The china baby plan was quickly cancelled
technologyreview.com/s/608086/baby-…
The china baby plan was quickly cancelled
technologyreview.com/s/608086/baby-…
I think another reason is that hard to compete in China anyway.
CEO Mirza Cifric tells me he can't talk right now about what's happening. "it is a very difficult situation requiring my full attention"
not everyone is so enthusiastic about the genome
aaand.. Here's the story from @chrissyfarr about Veritas Genetics going under. (apparently still servicing some Latam and European contracts tho)
cnbc.com/2019/12/05/ver…
cnbc.com/2019/12/05/ver…
@chrissyfarr Key intrigue. Getting China out of our genomes?
"The company’s investors, including Simcere Pharmaceutical and Lilly Asia Ventures, based in China, at a time when the Trump administration is cracking down on Chinese investment in U.S. companies."
"The company’s investors, including Simcere Pharmaceutical and Lilly Asia Ventures, based in China, at a time when the Trump administration is cracking down on Chinese investment in U.S. companies."
